KR950008534A - 트리펩티드 항혈전제 - Google Patents

트리펩티드 항혈전제 Download PDF

Info

Publication number
KR950008534A
KR950008534A KR1019940022961A KR19940022961A KR950008534A KR 950008534 A KR950008534 A KR 950008534A KR 1019940022961 A KR1019940022961 A KR 1019940022961A KR 19940022961 A KR19940022961 A KR 19940022961A KR 950008534 A KR950008534 A KR 950008534A
Authority
KR
South Korea
Prior art keywords
pharmaceutically acceptable
compound
antithrombotic
solvates
compounds
Prior art date
Application number
KR1019940022961A
Other languages
English (en)
Other versions
KR100312388B1 (ko
Inventor
데이비드 게젤첸 폴
데오도르 슈만 로버트
Original Assignee
피터지. 스트링거
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 피터지. 스트링거, 일라이 릴리 앤드 캄파니 filed Critical 피터지. 스트링거
Publication of KR950008534A publication Critical patent/KR950008534A/ko
Application granted granted Critical
Publication of KR100312388B1 publication Critical patent/KR100312388B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

본 발명은 (1R, 4aR, 8aR)-1, 2, 3, 4, 5, 6, 7, 8-퍼하이드로이소퀴놀린-1-카보닐-(L)-프롤리닐-(L)-아르기닌 알데하이드 및 그의 약학적으로 허용 가능한 염 및 용매화물, 이들 화합물을 포함하는 약제 및 트롬빈억제제, 응고 억제제 및 혈전색전증 치료제로서의 이들을 이용하는 방법에 관한 것이다.

Description

트리펩티드 항혈전제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 하기 일반식의 화합물 및 그의 약학적으로 허용가능한 염 및 용매화물;
    이다.
  2. 제1항의 화합물의 황산 염.
  3. 항혈전제로서의 제1항 또는 제2항에 따른 화합물의 용도.
  4. 하나 또는 그 이상의 약학적으로 허용가능한 담체, 부형제 또는 희석제는 결합된 제1항 또는 제2항에 따른 화합물을 활성성분으로 포함하는 약제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940022961A 1993-09-14 1994-09-13 트리펩티드항혈전제 KR100312388B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/121134 1993-09-14
US08/121,134 US5430023A (en) 1990-09-28 1993-09-14 Tripeptide antithrombotic agents

Publications (2)

Publication Number Publication Date
KR950008534A true KR950008534A (ko) 1995-04-19
KR100312388B1 KR100312388B1 (ko) 2001-12-28

Family

ID=22394776

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940022961A KR100312388B1 (ko) 1993-09-14 1994-09-13 트리펩티드항혈전제

Country Status (31)

Country Link
US (1) US5430023A (ko)
EP (1) EP0643073B1 (ko)
JP (1) JPH07149791A (ko)
KR (1) KR100312388B1 (ko)
CN (1) CN1055698C (ko)
AT (1) ATE160574T1 (ko)
AU (1) AU674773B2 (ko)
BR (1) BR9403542A (ko)
CA (1) CA2131982C (ko)
CO (1) CO4290364A1 (ko)
CY (1) CY2072B1 (ko)
CZ (1) CZ286139B6 (ko)
DE (1) DE69407006T2 (ko)
DK (1) DK0643073T3 (ko)
ES (1) ES2110186T3 (ko)
FI (1) FI944231A (ko)
GR (1) GR3026115T3 (ko)
HU (1) HU220620B1 (ko)
IL (1) IL110933A (ko)
MY (1) MY112879A (ko)
NO (1) NO310240B1 (ko)
NZ (1) NZ264438A (ko)
PE (1) PE43695A1 (ko)
PH (1) PH31655A (ko)
PL (1) PL176448B1 (ko)
RU (1) RU2105010C1 (ko)
SI (1) SI0643073T1 (ko)
TW (1) TW275622B (ko)
UA (1) UA32556C2 (ko)
YU (1) YU54194A (ko)
ZA (1) ZA947015B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102388531B1 (ko) * 2021-07-07 2022-04-21 이재호 특장차용 스마트 유압 시스템

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69314478T2 (de) * 1992-03-04 1999-02-11 Gyogyszerkutato Intezet Kft., Budapest Neuartige antikoagulierende peptidderivate und arzneimittel die solche enthalten so wie entsprechendes herstellungsverfahren
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
WO1995023809A1 (en) * 1994-03-04 1995-09-08 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5691356A (en) * 1994-03-21 1997-11-25 Bristol-Myers Squibb Company Disubstituted heterocyclic thrombin inhibitors
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US5919765A (en) * 1995-06-07 1999-07-06 Cor Therapeutics, Inc. Inhibitors of factor XA
US5721214A (en) * 1995-06-07 1998-02-24 Cor Therapeutics, Inc. Inhibitors of factor Xa
US6022861A (en) * 1995-06-07 2000-02-08 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6069130A (en) * 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6046169A (en) * 1995-06-07 2000-04-04 Cor Therapeutics, Inc. Inhibitors of factor XA
US6245743B1 (en) 1996-06-05 2001-06-12 Cor Therapeutics, Inc. Inhibitors of factor Xa
JP3539607B2 (ja) * 1997-02-19 2004-07-07 シャープ株式会社 空気調和機の運転制御システム
CA2289625A1 (en) 1997-05-15 1998-11-19 Charles Van Jackson Antithrombotic compound
US6903075B1 (en) 1997-05-29 2005-06-07 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
WO1999064395A1 (en) * 1998-06-11 1999-12-16 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6172081B1 (en) 1999-06-24 2001-01-09 Novartis Ag Tetrahydroisoquinoline 3-carboxamide derivatives
EP1482882B1 (en) * 2002-02-11 2011-09-14 Gold-T Tech, Inc. Implantable device for preventing thrombus formation
US7205315B2 (en) 2003-09-27 2007-04-17 Sanofi-Aventis Deutschland Gmbh Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
CN102391360B (zh) * 2011-11-02 2013-07-03 东南大学 一种抗血栓和血小板聚集的小肽

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU184368B (en) * 1981-01-13 1984-08-28 Gyogyszerkutato Intezet Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
DE3827415A1 (de) * 1988-08-12 1990-02-15 Behringwerke Ag Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102388531B1 (ko) * 2021-07-07 2022-04-21 이재호 특장차용 스마트 유압 시스템

Also Published As

Publication number Publication date
JPH07149791A (ja) 1995-06-13
DE69407006D1 (de) 1998-01-08
NO943402D0 (no) 1994-09-13
CY2072B1 (en) 1998-09-11
PL305009A1 (en) 1995-03-20
NO943402L (no) 1995-03-15
YU54194A (sh) 1997-01-08
CO4290364A1 (es) 1996-04-17
HU9402626D0 (en) 1994-11-28
DK0643073T3 (da) 1997-12-29
CN1106819A (zh) 1995-08-16
UA32556C2 (uk) 2001-02-15
ES2110186T3 (es) 1998-02-01
CZ286139B6 (cs) 2000-01-12
RU94034734A (ru) 1996-07-20
ATE160574T1 (de) 1997-12-15
GR3026115T3 (en) 1998-05-29
AU674773B2 (en) 1997-01-09
ZA947015B (en) 1996-03-12
MY112879A (en) 2001-10-31
CZ222094A3 (en) 1995-03-15
AU7294894A (en) 1995-03-30
PL176448B1 (pl) 1999-05-31
HUT67849A (en) 1995-05-29
SI0643073T1 (en) 1998-08-31
FI944231A (fi) 1995-03-15
TW275622B (ko) 1996-05-11
US5430023A (en) 1995-07-04
NO310240B1 (no) 2001-06-11
DE69407006T2 (de) 1998-04-16
CA2131982C (en) 2003-07-29
IL110933A0 (en) 1994-11-28
BR9403542A (pt) 1995-06-20
CN1055698C (zh) 2000-08-23
KR100312388B1 (ko) 2001-12-28
RU2105010C1 (ru) 1998-02-20
HU220620B1 (hu) 2002-03-28
IL110933A (en) 1998-12-27
PE43695A1 (es) 1995-12-09
EP0643073B1 (en) 1997-11-26
EP0643073A1 (en) 1995-03-15
CA2131982A1 (en) 1995-03-15
PH31655A (en) 1999-01-12
FI944231A0 (fi) 1994-09-13
NZ264438A (en) 1996-06-25

Similar Documents

Publication Publication Date Title
KR950008534A (ko) 트리펩티드 항혈전제
KR870005637A (ko) 약물 데포
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
EA200300873A1 (ru) Новая соль сукцинат o-десметилвенлафаксина
EA200000789A1 (ru) N-[(замещенное пятичленное ди- или триазадиненасыщенное кольцо) карбонил] гуанидиновые производные для лечения ишемии
ATE425139T1 (de) Benzamidinderivate
CA2258217A1 (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
RU95122135A (ru) Комбинация для профилактики и лечения спида, фармацевтическая композиция на ее основе
DK261490D0 (da) New pharmaceutical compound
KR910000703A (ko) 테트라졸 자극성 아미노산 수용체의 길항물질
KR890015742A (ko) 이병치료용 국소 제제
NO944371D0 (no) Kjemisk forbindelse med blodplateaggregeringsinhiberende virkning
EA199900374A1 (ru) Ингибитор вторичной катаракты
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
KR970061248A (ko) 알츠하이머병 치료용 1, 1, 2-트리페닐부트-1-엔 유도체
KR890003374A (ko) 정신 분열증 치료용 약제의 제조에 2-아미노-6-(트리플루오로메톡시)벤조티아졸의 이용
EP0466944A4 (en) 4h-3,1-benzoxazin-4-one compound and elastase inhibitor composition containing the same
KR910000645A (ko) 개선된 경련치료제
KR900701262A (ko) 췌장염 등에 대한 치료제
KR910018028A (ko) 15- 데히드록시-16-옥소프로스타글란딘 화합물에 의한 생화학적 치료
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
KR970704441A (ko) 사람 면역결핍증 바이러스 프로테아제 억제제 배합물(HIV Protease inhibitor combination)
FI895139A0 (fi) Pyrrolidinderivat.
KR960021045A (ko) 페루릭산을 포함하는 b형 간염 치료제

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee